Skip to main content

Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.

Publication ,  Journal Article
Qu, W; Wang, Z; Hare, JM; Bu, G; Mallea, JM; Pascual, JM; Caplan, AI; Kurtzberg, J; Zubair, AC; Kubrova, E; Engelberg-Cook, E; Nayfeh, T ...
Published in: Stem Cells Transl Med
September 2020

Severe cases of COVID-19 infection, often leading to death, have been associated with variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal stromal cells (MSCs) is a potential treatment for COVID-19 ARDS based on preclinical and clinical studies supporting the concept that MSCs modulate the inflammatory and remodeling processes and restore alveolo-capillary barriers. The authors performed a systematic literature review and random-effects meta-analysis to determine the potential value of MSC therapy for treating COVID-19-infected patients with ARDS. Publications in all languages from 1990 to March 31, 2020 were reviewed, yielding 2691 studies, of which nine were included. MSCs were intravenously or intratracheally administered in 117 participants, who were followed for 14 days to 5 years. All MSCs were allogeneic from bone marrow, umbilical cord, menstrual blood, adipose tissue, or unreported sources. Combined mortality showed a favorable trend but did not reach statistical significance. No related serious adverse events were reported and mild adverse events resolved spontaneously. A trend was found of improved radiographic findings, pulmonary function (lung compliance, tidal volumes, PaO2 /FiO2 ratio, alveolo-capillary injury), and inflammatory biomarker levels. No comparisons were made between MSCs of different sources.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Stem Cells Transl Med

DOI

EISSN

2157-6580

Publication Date

September 2020

Volume

9

Issue

9

Start / End Page

1007 / 1022

Location

England

Related Subject Headings

  • SARS-CoV-2
  • Respiratory Distress Syndrome
  • Pneumonia, Viral
  • Pandemics
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cell Transplantation
  • Lung
  • Humans
  • Cytokines
  • Coronavirus Infections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Qu, W., Wang, Z., Hare, J. M., Bu, G., Mallea, J. M., Pascual, J. M., … Sanfilippo, F. P. (2020). Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome. Stem Cells Transl Med, 9(9), 1007–1022. https://doi.org/10.1002/sctm.20-0146
Qu, Wenchun, Zhen Wang, Joshua M. Hare, Guojun Bu, Jorge M. Mallea, Jorge M. Pascual, Arnold I. Caplan, et al. “Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.Stem Cells Transl Med 9, no. 9 (September 2020): 1007–22. https://doi.org/10.1002/sctm.20-0146.
Qu W, Wang Z, Hare JM, Bu G, Mallea JM, Pascual JM, et al. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome. Stem Cells Transl Med. 2020 Sep;9(9):1007–22.
Qu, Wenchun, et al. “Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.Stem Cells Transl Med, vol. 9, no. 9, Sept. 2020, pp. 1007–22. Pubmed, doi:10.1002/sctm.20-0146.
Qu W, Wang Z, Hare JM, Bu G, Mallea JM, Pascual JM, Caplan AI, Kurtzberg J, Zubair AC, Kubrova E, Engelberg-Cook E, Nayfeh T, Shah VP, Hill JC, Wolf ME, Prokop LJ, Murad MH, Sanfilippo FP. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome. Stem Cells Transl Med. 2020 Sep;9(9):1007–1022.

Published In

Stem Cells Transl Med

DOI

EISSN

2157-6580

Publication Date

September 2020

Volume

9

Issue

9

Start / End Page

1007 / 1022

Location

England

Related Subject Headings

  • SARS-CoV-2
  • Respiratory Distress Syndrome
  • Pneumonia, Viral
  • Pandemics
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cell Transplantation
  • Lung
  • Humans
  • Cytokines
  • Coronavirus Infections